Will Viking Therapeutics Get Acquired?
The Motley Fool
MARCH 16, 2024
Investors have become excited about the company's long-term prospects, as it has a promising weight-loss drug in its portfolio. And in a time when weight-loss drugs are all the rage in healthcare, investors are more than just a little optimistic about how much higher the stock can go.
Let's personalize your content